HB 1262 CO
Patient Access to Compounded Medical Items
A state bill is a proposed law in a state legislature — separate from the U.S. Congress. Learn more →
Summary
This bill expands patient access to compounded drugs and medical devices in Colorado. It permits licensed pharmacies and federally registered compounding facilities to supply compounded drugs and devices to healthcare providers and facilities, and allows providers to obtain, dispense, and administer these compounded medications and devices in compliance with applicable federal and state law. The bill prohibits the state pharmacy board from adopting rules that are more restrictive than federal or state law regarding compounding by registered outsourcing facilities. The bill also adds exemptions for investigational drugs and compounded drugs and devices that comply with federal and state law.
AI-generated plain-language summary of the bill (from the OpenStates abstract — no full text available yet) — neutral, and may be imperfect.
Official abstract
The act provides that, if the action is undertaken in accordance with applicable federal and state law:A licensed person may compound a drug or device in the state;A state-licensed pharmacy or a distribution facility registered with the federal food and drug administration (licensed 503B outsourcing facility) may supply a compounded drug or device to a licensed health-care provider, pharmacy, facility, or organization; andA licensed health-care provider, pharmacy, facility, or organization may obtain, dispense, or administer a compounded drug or device supplied by a state-licensed pharmacy or a licensed 503B outsourcing facility. In addition, the act prohibits the state board of pharmacy from adopting rules that are more restrictive than federal or state law regarding the compounding of drugs or devices by licensed 503B outsourcing facilities. Current law exempts drugs that are intended solely for investigational use by experts qualified by scientific training and experience and that are plainly labeled for investigational use only from the sales and delivery prohibition for new drugs. The act also exempts from the prohibition:Drugs that are reviewed by an institutional review board and plainly labeled for investigational use only; andCompounded drugs and devices if the compounding of the drug or device is undertaken in accordance with applicable federal and state law.(Note: This summary applies to this bill as enacted.)
Sponsors (4)
- K. Stewart Democratic · sponsor
- R. Stewart Democratic · sponsor
- M. Ball Democratic · sponsor
- D. Roberts Democratic · sponsor
22 coauthors / cosponsors
- J. Bacon Democratic · cosponsor
- K. Brown Democratic · cosponsor
- C. Clifford Democratic · cosponsor
- M. Duran Democratic · cosponsor
- C. Espenoza Democratic · cosponsor
- L. García Democratic · cosponsor
- E. Hamrick Democratic · cosponsor
- J. Jackson Democratic · cosponsor
- J. Joseph Democratic · cosponsor
- S. Lieder Democratic · cosponsor
- M. Lindsay Democratic · cosponsor
- B. Marshall Democratic · cosponsor
- J. McCluskie Democratic · cosponsor
- K. McCormick Democratic · cosponsor
- K. Nguyen Democratic · cosponsor
- J. Phillips Democratic · cosponsor
- N. Ricks Democratic · cosponsor
- M. Rutinel Democratic · cosponsor
- E. Sirota Democratic · cosponsor
- L. Smith Democratic · cosponsor
- B. Titone Democratic · cosponsor
- R. Weinberg Republican · cosponsor
Action history (15)
- Jun 2, 2026 Governor Signed · executive
- May 22, 2026 Sent to the Governor · executive
- May 22, 2026 Signed by the President of the Senate · upper
- May 22, 2026 Signed by the Speaker of the House · lower
- Apr 21, 2026 House Considered Senate Amendments - Result was to Concur - Repass · lower
- Apr 20, 2026 House Considered Senate Amendments - Result was to Laid Over Daily · lower
- Apr 17, 2026 Senate Third Reading Passed - No Amendments · upper
- Apr 16, 2026 Senate Second Reading Passed with Amendments - Committee · upper
- Apr 14, 2026 Senate Second Reading Laid Over to 04/16/2026 - No Amendments · upper
- Apr 9, 2026 Senate Committee on Health & Human Services Refer Amended - Consent Calendar to Senate Committee of the Whole · upper
- Mar 19, 2026 Introduced In Senate - Assigned to Health & Human Services · upper
- Mar 16, 2026 House Third Reading Passed - No Amendments · lower
- Mar 13, 2026 House Second Reading Special Order - Passed with Amendments - Floor · lower
- Mar 10, 2026 House Committee on Health & Human Services Refer Unamended to House Committee of the Whole · lower
- Feb 19, 2026 Introduced In House - Assigned to Health & Human Services · lower
Full text
The full text hasn’t been imported yet. CivicGate fetches it from the state legislature’s published version documents — check now.
Comments
Data from OpenStates. View on OpenStates →
Comments